tiprankstipranks

AbbVie price target raised to $212 from $200 at Barclays

Barclays raised the firm’s price target on AbbVie to $212 from $200 and keeps an Overweight rating on the shares as part of an earnings preview for the biopharmaceutical group. The firm sees a challenging large-cap biopharma setup for Q3.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue